News

Fresh Start Surgical Gifts Presents the 2023 Annual Oktoberfest Butterfly Gala: A Night of Hope and Transformation

SAN DIEGO, Sept. 18, 2023 /PRNewswire/ — National nonprofit, Fresh Start Surgical Gifts is excited to announce its highly anticipated 2023 Annual Oktoberfest Butterfly Gala, a celebration that promises an unforgettable evening of transforming lives, […]

News

Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update

SAN DIEGO, Sept. 18, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (NASDAQ: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its […]

News

Moderna’s R&D game plan; 2seventy layoffs amid CAR-T slowdown; Covid vaccine boosters get thumbs up; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

News

Phil Vickers talks new role as head of Longwood’s Solu after Faze shutdown; Regeneron CFO to retire in February

Phil Vickers Phil Vickers started last week as president and CEO of Solu Therapeutics, a Longwood Fund startup developing small molecule-antibody chimeras. He takes the place of Longwood executive partner David Donabedian, who has taken […]

News

Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board

SAN DIEGO, Sept. 14, 2023 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today announced that Professor Shun Lu, an internationally renowned oncologist […]

News

The Deerborne Group Publishes Comprehensive Article on Navigating the Molecular Diagnostics Reimbursement Process

New publication identifies best-practices and highlights actionable steps organizations can take to ensure the successful navigation of the MolDx process SAN DIEGO, Sept. 14, 2023 /PRNewswire/ — The Deerborne Group, a genomics and precision diagnostics […]

News

Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Application for INGREZZA® (valbenazine) Oral Granules Sprinkle Formulation

Prescription Drug User Fee Act (PDUFA) Target Action Date Set for April 30, 2024 SAN DIEGO, Sept. 14, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration (FDA) […]

News

Xylazine Has Spread to Every Region of the Country, Millennium Health Signals Report™ Shows

SAN DIEGO–(BUSINESS WIRE)–According to the Millennium Health Signals Report released today, the powerful, veterinary tranquilizer xylazine—also known as “tranq”—was detected in urine drug tests from every region of the country, with the highest rates in […]

News

Tyra Biosciences to Participate at 2023 Cantor Global Healthcare Conference

CARLSBAD, Calif., Sept. 12, 2023 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced… […]